Gout can absolutely affect different joints over time, and many people experience flares that seem to “move” from one joint to another. What’s actually happening is that uric acid crystals build up in multiple joints throughout the body, and inflammation can flare in any joint where those crystals are present. So while it feels like gout is migrating, it’s more accurate to say that new deposits are triggering separate inflammatory episodes in different locations.
Why Gout Appears to Move
Gout is caused by monosodium urate crystals depositing in joints, soft tissues, and bones. These crystals can sit quietly in a joint for a long time without triggering any symptoms. Imaging studies have confirmed that urate crystals can be present in joints for prolonged periods without causing an obvious inflammatory reaction. When a flare does happen, it’s typically set off by microcrystals shed from existing crystal deposits in the joint lining.
This means you can have crystal buildup in your big toe, ankle, knee, and wrist all at once, but only experience a painful flare in one of those joints at a time. When the big toe calms down and the knee flares up a week later, it feels like the gout traveled. In reality, both joints had crystals waiting to cause trouble.
The Typical Joint-to-Joint Progression
Early gout almost always starts as a single-joint problem, most commonly in the big toe. The ankle and midfoot are the next most frequent targets. As the disease progresses (especially without treatment), flares start showing up in more joints and occurring more frequently. Over time, attacks tend to become less explosively severe but involve a greater number of joints simultaneously.
The general pattern follows a bottom-to-top trajectory through the body. Lower extremity joints like the big toe, midfoot, ankle, and knee are hit first. Upper body joints come later: the elbow (particularly the bursa overlying it), then the fingers and wrists. The shoulder and hip are very rarely affected by gout, even in advanced cases. This progression can take years, but without adequate treatment, the pattern of spreading to new joints is predictable.
When Multiple Joints Flare at Once
In poorly controlled gout, the disease can shift from isolated flares in a single joint to polyarticular attacks, where several joints are inflamed at the same time. This stage also brings painful symptoms between acute flares, meaning you may never feel completely free of joint discomfort. At this point, visible deposits of uric acid crystals called tophi can form in and around joints and soft tissues.
Tophi commonly appear on the ears, fingers, toes, wrists, knees, over the Achilles tendon, and on the elbows. These chalky deposits aren’t just cosmetic. They signal that crystal buildup has become extensive, and they can cause erosive damage to the joint itself. When gout reaches this chronic stage with multiple joint involvement, it can closely mimic rheumatoid arthritis, sometimes enough to lead to misdiagnosis. The key difference is that rheumatoid arthritis tends to affect joints symmetrically (both hands, both wrists), while gout more often hits joints asymmetrically and favors the lower extremities, at least initially.
What Drives the Spread
The underlying cause is persistently elevated uric acid in the blood. When uric acid levels stay above a certain threshold, crystals continue depositing in new joints over months and years. Every joint that accumulates enough crystals becomes a potential site for the next flare. The longer uric acid stays elevated, the more joints get “seeded” with crystals, and the more widespread the disease becomes.
Certain factors can accelerate this process. Dehydration concentrates uric acid in the blood. Purine-rich foods and alcohol increase uric acid production. Kidney function plays a major role, since most uric acid leaves the body through the kidneys. Any combination of these factors can push crystal formation into joints that were previously unaffected.
Preventing Gout From Spreading
The most effective way to stop gout from recruiting new joints is to lower blood uric acid levels enough that existing crystals dissolve and new ones stop forming. Urate-lowering therapy accomplishes this by suppressing uric acid production. When used early and consistently, these medications prevent painful flares, dissolve existing crystal deposits (including tophi), and can effectively cure the disease by eliminating the crystals that cause it.
This is a meaningful distinction from just treating flares as they happen. Anti-inflammatory medications handle the pain of an individual attack, but they do nothing to address the crystal buildup driving the disease forward. Without urate-lowering therapy, flares tend to increase in frequency, involve more joints, and eventually cause permanent erosive damage and disability. Starting treatment earlier in the disease course, before multiple joints are involved, leads to better outcomes and a shorter path to being flare-free.
If your gout has already started appearing in new joints, that’s a strong signal that your uric acid levels have been too high for too long. It doesn’t mean the damage is irreversible. Crystal deposits can dissolve with sustained treatment, and joints that were actively flaring can quiet down permanently once the uric acid crystals are gone.

